Kratom products; modifying certain definitions. Effective date.
Summary
SB 183 amends the Oklahoma Kratom Consumer Protection Act by revising several statutory definitions that govern kratom products sold in the state. The bill defines “kratom leaf,” “kratom leaf extract,” “kratom product,” “total kratom alkaloids,” and “vendor” more precisely, including limits on alkaloid content, requirements for extraction methods, and restrictions on synthesized kratom alkaloids, constituents, and metabolites. It also updates the statutory reference to the existing act and sets an effective date of November 1, 2025.
Under the bill, kratom leaf must be minimally processed and may only undergo drying, size reduction, cleaning, sterilization, or similar standard food-ingredient treatments, with total alkaloid content capped at 3.5% on a dried weight basis. Kratom leaf extract must be made using specified solvents or other solvents allowed for food ingredients, and the extract must preserve mitragynine as the dominant alkaloid at a specified ratio relative to other alkaloids. A kratom product may not contain synthesized kratom compounds and must keep 7-hydroxymitragynine below 1% of total kratom alkaloids, verified by high-performance liquid chromatography testing.
Impact
The bill would amend Title 63 provisions within the Oklahoma Kratom Consumer Protection Act, tightening and clarifying the legal definitions that determine which kratom-containing foods and dietary supplements may be sold in Oklahoma. It affects manufacturers, wholesalers, retailers, and other vendors by establishing product composition standards and testing-related criteria that products must meet to remain compliant under state law.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate or formal support/opposition in the available materials. Based on the bill text alone, the measure appears regulatory rather than prohibitive, suggesting an intent to standardize the market and protect consumers while preserving lawful kratom sales. The overall tone of the legislation is technical and compliance-focused.
Contention
The main potential points of contention are the product restrictions and testing standards, especially the ban on synthesized kratom alkaloids and the limits on 7-hydroxymitragynine and total alkaloid content. Vendors and manufacturers may view these requirements as burdensome or restrictive, while consumer safety advocates may support them as necessary to prevent adulterated or overly potent products. Another possible issue is the bill’s reliance on specific laboratory testing methods and chemical definitions, which could raise questions about enforcement and compliance costs.